Terms: = Endocrine gland cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Prognosis
11 results:
1. Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study.
Yang J; Zhou H; Li H; Zhao F; Tong K
BMC Cancer; 2024 Feb; 24(1):193. PubMed ID: 38347528
[TBL] [Abstract] [Full Text] [Related]
2. Pituitary adenomas registry in Thailand.
Kwancharoen R; Deerochanawong C; Peerapatdit T; Salvatori R
J Clin Neurosci; 2023 Sep; 115():138-147. PubMed ID: 37572520
[TBL] [Abstract] [Full Text] [Related]
3. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
[TBL] [Abstract] [Full Text] [Related]
4. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
Zhao R; Ren S; Li C; Guo K; Lu Z; Tian L; He J; Zhang K; Cao Y; Liu S; Li D; Wang Z
Cancer Med; 2023 Feb; 12(4):5158-5171. PubMed ID: 36161527
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
[TBL] [Abstract] [Full Text] [Related]
6. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic cancer Undergoing Resection.
Ren W; Xourafas D; Ashley SW; Clancy TE
Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.
McLellan P; Henriques J; Ksontini F; Doat S; Hammel P; Desrame J; Trouilloud I; Louvet C; Pietrasz D; Vernerey D; Bachet JB
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101541. PubMed ID: 33055007
[TBL] [Abstract] [Full Text] [Related]
8. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract] [Full Text] [Related]
9. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis.
Ruiz J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Endocrinol Diabetes Nutr (Engl Ed); 2020 May; 67(5):317-325. PubMed ID: 31882257
[TBL] [Abstract] [Full Text] [Related]
10. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
[TBL] [Abstract] [Full Text] [Related]
11. Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid cancer: A Meta-Analysis.
Malandrino P; Russo M; Regalbuto C; Pellegriti G; Moleti M; Caff A; Squatrito S; Vigneri R
Thyroid; 2016 Sep; 26(9):1285-92. PubMed ID: 27349273
[TBL] [Abstract] [Full Text] [Related]
